Navigation Links
Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
Date:12/19/2007

oned not to place undue reliance on these forward- looking statements, which speak only as of the date hereof. All forward- looking statements are qualified in their entirety by this cautionary statement and Amicus undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... recipient,s immune system identifies the transplanted organ as foreign ... T cells, the immune cells that mediate rejection, must ... order to migrate to the transplanted organ. In this ... Fadi Lakkis and colleagues at the University of Pittsburgh ... cells is not required for migration. Instead, these cells ...
(Date:5/17/2013)... - Elsevier, a world-leading provider of scientific, technical and ... of a recent study in Reproductive BioMedicine ... that those with an abnormal chromosomal composition can be ... to blastocysts, thereby classifying the risk of genetic abnormality ... group has undertaken a retrospective study, using their predictive ...
(Date:5/17/2013)... TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... and insect pressures , Syngenta ... opening celebration today at the company’s RTP Innovation Center. ... Lab allows company researchers to simulate any agricultural climate ...
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... China , May 25 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. ... a leading over-the-counter Hepatitis B medicine,Xin Aoxing Oleanolic Acid Capsule ("Xin ... that it has,commenced assembly of its production line for its proprietary ... , ...
... , NEW YORK , May 25 Pfizer Animal ... in aquaculture vaccines, R&D and healthcare diagnostic services.  The acquisition further expands ... cattle, swine, poultry and, now, fish. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ) , ...
... 25 Today Organic Miracle, Inc. CEO Jerry Bakke , ... have developed a natural, non-toxic solution to the Gulf oil spill contamination ... , , , ... 701 (Building a Better World Green) is a super concentrated, high efficiency, ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 2Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 3Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 4Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 2Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 3Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 4Organic Miracle, Inc.'s Product, BBW G701, is a Natural, Non-Toxic Means of Stopping and Reversing the Catastrophic Contamination Caused by the Gulf Oil Spill 2
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/15/2013)... gout risk, new research reveals that vitamin C, also ... levels to a clinically significant degree in patients with ... with allopurinol, appears to have a weak effect on ... the results published in the American College of Rheumatology ... Gout is an inflammatory arthritis that causes excruciating pain ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Clinicians, researchers and allied health professionals with ... and management, are invited to convene in Singapore ... Meeting from December 10-13, 2010. The ... lectures by key international experts and thought leaders ...
... 2010) Rare but devastating, eye cancer can strike anyone ... leaves half of all patients partially blind. But a ... the University of Colorado School of Medicine, may change all ... the eye can block up to 55 percent of harmful ...
... broken by Michigan State University biochemists helps explain ... could lead to discoveries related to plant tolerance ... brings together two classic problems in plant biology," ... molecular biology. "One is that plants protect themselves ...
Cached Biology News:Clinical management of osteoporosis to be focus of Singapore meeting 2Researcher finds revolutionary way to treat eye cancer 2Researchers discover novel mechanism protecting plants against freezing 2